|
271 Companies |
|
374 Products |
|
374 Products |
|
160 Mechanisms of Action |
|
34 Trials |
|
5514 News |
|
| «12...9899100101102103104105106107108...110111» |
- Enrollment open: Cervical Cancer Screening Project Part C (clinicaltrials.gov) - Jun 5, 2012
P=N/A, N=60, Recruiting, Sponsor: Masonic Cancer Center, University of Minnesota
Not yet recruiting --> Recruiting
- | cisplatin / Generic mfg.
Enrollment open, Metastases: Tri-weekly Cisplatin Based Chemoradiation in Locally Advanced Cervical Cancer (clinicaltrials.gov) - Jun 5, 2012
P3, N=590, Recruiting, Sponsor: Korea Cancer Center Hospital
Not yet recruiting --> Recruiting Active, not recruiting --> Recruiting
- arzoxifene (LY353381) / Eli Lilly
Trial completion, Metastases: Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Metastatic Refractory Ovarian Cancer or Primary Peritoneal Cancer (clinicaltrials.gov) - Jun 5, 2012
P2, N=0, Completed, Sponsor: Eli Lilly and Company
Active, not recruiting --> Recruiting Active, not recruiting --> Completed
- arzoxifene (LY353381) / Eli Lilly
Trial completion, Metastases: Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Recurrent, Advanced, or Metastatic Endometrial Cancer (clinicaltrials.gov) - Jun 5, 2012
P2, N=0, Completed, Sponsor: Eli Lilly and Company
Active, not recruiting --> Completed Active, not recruiting --> Completed
- tigatuzumab (CS-1008) / Daiichi Sankyo
Enrollment change: The Effect of TRA-8 on Ovarian Cancer Tissue (clinicaltrials.gov) - Jun 4, 2012
P=N/A, N=478, Completed, Sponsor: University of Alabama at Birmingham
Active, not recruiting --> Completed N=120 --> 478
- |||| Qinprezo (vosaroxin) / Denovo
Trial completion: Safety and Efficacy Clinical Study of SNS-595 in Patients With Platinum-Resistant Ovarian Cancer (clinicaltrials.gov) - Jun 4, 2012
P2, N=143, Completed, Sponsor: Sunesis Pharmaceuticals
N=120 --> 478 Active, not recruiting --> Completed
- || New P3 trial: Optimum Misoprostol Dose Prior to Office Hysteroscopy (clinicaltrials.gov) - Jun 3, 2012
P3, N=132, Completed, Sponsor: Cairo University
- | Trial completion: The Effect of Androgen and Growth Hormone on Height and Learning in Girls With Turner Syndrome (clinicaltrials.gov) - Jun 3, 2012
P3, N=200, Completed, Sponsor: Thomas Jefferson University
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | iniparib (BSI 201) / Sanofi
Enrollment change, Metastases: Single Arm Study of BSI-201 in Patients With BRCA-1 or BRCA-2 Associated Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (clinicaltrials.gov) - Jun 3, 2012
P2, N=12, Completed, Sponsor: Sanofi
Active, not recruiting --> Completed N=35 --> 12
- Enrollment change: Treatment of Menorrhagia in Women With Thrombocytopenia Using Platelets or Platelets and Hormones (clinicaltrials.gov) - Jun 1, 2012
P1/2, N=1, Terminated, Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
N=35 --> 12 N=42 --> 1
- Enrollment change: Pilot Evaluation of 124I-Iodo-Azomycin Galacto-Pyranoside (*IAZGP) Positron Emission Tomography (PET) in the Imaging of Hypoxic Tumors (clinicaltrials.gov) - May 31, 2012
P=N/A, N=15, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
N=42 --> 1 N=20 --> 15
- Trial completion: Pilot Evaluation of 124I-Iodo-Azomycin Galacto-Pyranoside (*IAZGP) Positron Emission Tomography (PET) in the Imaging of Hypoxic Tumors (clinicaltrials.gov) - May 31, 2012
P=N/A, N=15, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
N=20 --> 15 Active, not recruiting --> Completed
- Trial completion: FLASH: The Role of Vitamin D in Menopause: Relationship to Menopausal Symptoms in Body Composition (clinicaltrials.gov) - May 30, 2012
P1, N=23, Completed, Sponsor: Kaiser Permanente
Active, not recruiting --> Completed Not yet recruiting --> Completed
- | triptorelin / Generic mfg.
New P4 trial: Trial Comparing hCG Triggering Versus hCG Associated With GnRH Agonist (clinicaltrials.gov) - May 28, 2012
P4, N=120, Recruiting, Sponsor: AZ Jan Palfijn Gent
- | Votrient (pazopanib) / Novartis, BeiGene
New P1 trial, Combination therapy: PAZPET-1: [18F]Fluciclatide-PET, Pazopanib and Paclitaxel in Ovarian Cancer (clinicaltrials.gov) - May 28, 2012
P1, N=17, Recruiting, Sponsor: Imperial College London
- carboplatin / Generic mfg.
Trial completion: Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer (clinicaltrials.gov) - May 28, 2012
P1/2, N=63, Completed, Sponsor: AGO Study Group
Not yet recruiting --> Completed Active, not recruiting --> Completed
- Ovidrel (choriogonadotropin alfa) / EMD Serono, Vagifem (estradiol) / Novo Nordisk, Estrofem (estradiol oral) / Novo Nordisk
Enrollment open: The Luteal Phase After GnRHa Trigger - a Proof of Concept Study (clinicaltrials.gov) - May 25, 2012
P4, N=180, Recruiting, Sponsor: Regionshospitalet Viborg, Skive
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- | Trial termination, Biopsy: Preimplantation Genetic Diagnosis (PGD) by Array Comparative Genome Hybridization (CGH) and Blastocyst Biopsy (clinicaltrials.gov) - May 24, 2012
P3, N=120, Terminated, Sponsor: Reprogenetics
Not yet recruiting --> Recruiting Recruiting --> Terminated; Not enough patients enrolling
- leuprolide acetate for depot suspension / Generic mfg.
Gene Expression Profile, Biopsy: Gene Expression Profile After Gonadotropin Releasing Hormone (GnRH) Agonist Trigger of Oocyte Maturation (clinicaltrials.gov) - May 24, 2012
P=N/A, N=20, Enrolling by invitation, Sponsor: University of Connecticut Health Center
- Trial termination: Canadian Varicocelectomy Initiative (CVI): Effects on Male Fertility and Testicular Function of Varicocelectomy (clinicaltrials.gov) - May 23, 2012
P=N/A, N=300, Terminated, Sponsor: Mount Sinai Hospital, Canada
Recruiting --> Terminated; Not enough patients enrolling Not yet recruiting --> Terminated
- || Enrollment closed: Single Embryo Transfer of a Euploid Embryo Versus Double Embryo Transfer (clinicaltrials.gov) - May 23, 2012
P=N/A, N=200, Active, not recruiting, Sponsor: Reproductive Medicine Associates of New Jersey
Not yet recruiting --> Terminated Recruiting --> Active, not recruiting
- Trial completion: The Potential Effects of Inofolic Plus on Abnormal Ovarian Reserve Parameters in Subfertile Women (clinicaltrials.gov) - May 23, 2012
P=N/A, N=15, Completed, Sponsor: Palm Beach Center for Reproductive Medicine
Recruiting --> Active, not recruiting Recruiting --> Completed
- Trial completion: SMILE: Pain, Sexual Dysfunction, and Depression in Hemodialysis Patients (clinicaltrials.gov) - May 23, 2012
P=N/A, N=315, Completed, Sponsor: Department of Veterans Affairs
Recruiting --> Completed Active, not recruiting --> Completed
- Trial withdrawal: Collection of Biospecimen & Clinical Information in Patients w/ Gastrointestinal Cancers (clinicaltrials.gov) - May 23, 2012
P=N/A, N=0, Withdrawn, Sponsor: Stanford University
Active, not recruiting --> Completed Not yet recruiting --> Withdrawn
- Enrollment change: Collection of Biospecimen & Clinical Information in Patients w/ Gastrointestinal Cancers (clinicaltrials.gov) - May 23, 2012
P=N/A, N=0, Withdrawn, Sponsor: Stanford University
Not yet recruiting --> Withdrawn N=10000 --> 0
- ||| Gardasil (quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine) / UniQuest
Enrollment closed: V501 Safety and Efficacy Study in Japanese Women Aged 16 to 26 Years (V501-110) (clinicaltrials.gov) - May 23, 2012
P4, N=1000, Active, not recruiting, Sponsor: Merck Sharp & Dohme Corp.
N=10000 --> 0 Recruiting --> Active, not recruiting
- | iniparib (BSI 201) / Sanofi
Enrollment change, PARP Biomarker, Metastases: Evaluation of Paclitaxel (Taxol, NSC #673089), Carboplatin (Paraplatin, NSC #241240), and BSI-201 (NSC #746045, IND #71,677) in the Treatment of Advanced, Persistent, or Recurrent Uterine Carcinosarcoma (clinicaltrials.gov) - May 22, 2012
P2, N=22, Completed, Sponsor: Sanofi
Recruiting --> Active, not recruiting N=45 --> 22
- | iniparib (BSI 201) / Sanofi
Trial completion, PARP Biomarker, Metastases: Evaluation of Paclitaxel (Taxol, NSC #673089), Carboplatin (Paraplatin, NSC #241240), and BSI-201 (NSC #746045, IND #71,677) in the Treatment of Advanced, Persistent, or Recurrent Uterine Carcinosarcoma (clinicaltrials.gov) - May 22, 2012
P2, N=22, Completed, Sponsor: Sanofi
N=45 --> 22 Active, not recruiting --> Completed
- Gardasil (quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine) / UniQuest
Trial completion: PERCAPS: The Development of a "Mother/Child, Screen, Treat and Vaccinate Program" in Manchay and Iquitos, Peru (clinicaltrials.gov) - May 22, 2012
P1, N=642, Completed, Sponsor: Preventive Oncology International, Inc.
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||| Norditropin (somatropin) / Novo Nordisk
Clinical: Non-interventional Study of Patients Using Norditropin® for Growth Hormone Deficiency or Turner Syndrome (clinicaltrials.gov) - May 21, 2012
P=N/A, N=2000, Enrolling by invitation, Sponsor: Novo Nordisk
- menotropin / Generic mfg.
New P1 trial: Highly Purified Menotropin (HP-hMG) Versus Recombinant FSH (rFSH) Plus Recombinant LH (rLH) in Intrauterine Insemination Cycles in Women ?35 Years: a Prospective Randomized Trial. (clinicaltrials.gov) - May 21, 2012
P1, N=300, Completed, Sponsor: Catholic University of the Sacred Heart
- | New P2 trial: LNGIUSAD: LNG-IUS for Treatment of Dysmenorrhea (clinicaltrials.gov) - May 16, 2012
P2, N=62, Active, not recruiting, Sponsor: Omar Mamdouh Shaaban
- New P1 trial: Improving IVF Embryo Quality Grading Using Polarized Light (clinicaltrials.gov) - May 15, 2012
P1, N=200, Not yet recruiting, Sponsor: Hadassah Medical Organization
- Enrollment open, Surgery: Pilot Study Using a PET Gamma Probe to Evaluate Lymph Nodes in Endometrial Cancer (clinicaltrials.gov) - May 13, 2012
P=N/A, N=18, Recruiting, Sponsor: University Health Network, Toronto
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- | Trial completion: Efficacy Study of the Vaginal Gel Carraguard to Prevent HIV Transmission (clinicaltrials.gov) - May 13, 2012
P3, N=6203, Completed, Sponsor: Population Council
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- Enrollment closed: A Study Comparing Mirena and Systemic Progestin for Endometrial Hyperplasia (clinicaltrials.gov) - May 10, 2012
P4, N=170, Active, not recruiting, Sponsor: University Hospital of North Norway
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- Clinical: Home-sampling in Partner Notification of Chlamydia (clinicaltrials.gov) - May 9, 2012
P=N/A, N=633, Completed, Sponsor: Ostergotland County Council, Sweden
- Biomarker, Trial withdrawal: Molecular Markers of Human Sperm Function (clinicaltrials.gov) - May 8, 2012
P=N/A, N=0, Withdrawn, Sponsor: National Institute of Environmental Health Sciences (NIEHS)
Recruiting --> Active, not recruiting Not yet recruiting --> Withdrawn
- Biomarker, Enrollment change: Molecular Markers of Human Sperm Function (clinicaltrials.gov) - May 8, 2012
P=N/A, N=0, Withdrawn, Sponsor: National Institute of Environmental Health Sciences (NIEHS)
Not yet recruiting --> Withdrawn N=356 --> 0
- Cytovene (ganciclovir) / Roche
Enrollment change, Viral vector: A Study of an Infectivity Enhanced Suicide Gene Expressing Adenovirus for Ovarian Cancer in Patients With Recurrent Ovarian and Other Selected Gynecologic Cancers (clinicaltrials.gov) - May 8, 2012
P1, N=11, Completed, Sponsor: University of Alabama at Birmingham
N=356 --> 0 N=14 --> 11
- | New P1 trial: A Pilot Study to Evaluate the Effect of Pomegranate Juice on Semen Parameters in Healthy Male Volunteers (clinicaltrials.gov) - May 8, 2012
P1, N=12, Completed, Sponsor: POM Wonderful LLC
- Metastases: Validation of a Laparoscopic Score to Predict the Chance of Optimal Cytoreduction in Advanced Ovarian Cancer Patients (clinicaltrials.gov) - May 7, 2012
P=N/A, N=163, Completed, Sponsor: Catholic University of the Sacred Heart
- metformin / Generic mfg.
Clinical: Metformin in Pregnancy in Women With Polycystic Ovary Syndrome (clinicaltrials.gov) - May 7, 2012
P=N/A, N=60, Completed, Sponsor: Catholic University of the Sacred Heart
- New P1 trial: The Clinical Impact of Selecting Acrosome Reacted Spermatozoa for ICSI (clinicaltrials.gov) - May 7, 2012
P1, N=100, Not yet recruiting, Sponsor: Hadassah Medical Organization
- Trial termination: Study of Emu Oil vs. Placebo for Vulvar Pain in Women. (clinicaltrials.gov) - May 6, 2012
P=N/A, N=1, Terminated, Sponsor: William Beaumont Hospitals
N=14 --> 11 Recruiting --> Terminated; enrollment volume due to placebo arm of trial
- Enrollment change: Study of Emu Oil vs. Placebo for Vulvar Pain in Women. (clinicaltrials.gov) - May 6, 2012
P=N/A, N=1, Terminated, Sponsor: William Beaumont Hospitals
Recruiting --> Terminated; enrollment volume due to placebo arm of trial N=30 --> 1
- | Trial completion, Preclinical: Basal Androgens and LH Needing for Ovarian Stimulation for in Vitro Fertilization (clinicaltrials.gov) - May 6, 2012
P3, N=400, Completed, Sponsor: Instituto Valenciano de Infertilidad, Spain
N=30 --> 1 Recruiting --> Completed
- Zyclara (imiquimod) / Mochida, Viatris, Bausch Health
Biomarker, New P2 trial: Identification of Novel Biomarkers of Cervicovaginal Mucosal Inflammation (clinicaltrials.gov) - May 3, 2012
P2, N=39, Completed, Sponsor: CONRAD
- ||||| Solithera (solithromycin) / Melinta Therap, Fujifilm Holdings
New P2 trial: Safety and Efficacy Study of Single-Dose Oral CEM-101 in Patients With Uncomplicated Urogenital Gonorrhea (clinicaltrials.gov) - May 2, 2012
P2, N=60, Completed, Sponsor: Cempra Pharmaceuticals
- | cabergoline / Generic mfg.
Biomarker, Enrollment open: Study of Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome (OHSS) in In Vito Fertilization Cycles and Derivation of OHSS Biomarkers (clinicaltrials.gov) - May 1, 2012
P3, N=540, Recruiting, Sponsor: KK Women's and Children's Hospital
Recruiting --> Completed Not yet recruiting --> Recruiting